Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis

Immunobiology

Volumn 218, Issue 3, 2013, Pages 402-407

  Lunin, S M ^a   Glushkova, O V ^a   Khrenov, M O ^a   Novoselova, T V ^a   Parfenyuk, S B ^a   Fesenko, E E ^a   Novoselova, E G ^a  

^a INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

Author keywords

EAE; Interferon gamma; Interleukin 17; NF kappaB; Thymopentin; Thymulin

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN 72; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 17; INTERLEUKIN 6; MYELIN BASIC PROTEIN; THYMOPENTIN; THYMULIN; THYMUS PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SPLEEN LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HSP72 HEAT-SHOCK PROTEINS; HUMANS; MALE; MICE; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; NF-KAPPA B; TH1 CELLS; TH17 CELLS; THYMIC FACTOR, CIRCULATING; THYMOPOIETINS; THYMUS GLAND;

EID: 84873196161     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.023     Document Type: Article

References (31)

1. Brereton C.F., Sutton C.E., Lalor S.J., Lavelle E.C., Mills K.H. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 2009, 183(3):1715-1723.
2. Brück W., Sommermeier N., Bergmann M., Zettl U., Goebel H.H., Kretzschmar H.A., Lassmann H. Macrophages in multiple sclerosis. Immunobiology 1996, 195:588-600.
3. Dardenne M., Saade N., Safieh-Garabedian B. Role of thymulin or its analogue as a new analgesic molecule. Ann. N.Y. Acad. Sci. 2006, 1088:153-163.
4. Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 2006, 72(9):1161-1179.
5. El-Behi M., Rostami A., Ciric B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 2010, 5:189-197.
6. Goverman Autoimmune T-cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9(6):393-407.
7. Haddad J.J. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. Mol. Immunol. 2009, 47:205-214.
8. Henriques-Coelho T., Oliveira S.M., Moura R.S., Roncon-Albuquerque R., Neves A.L., Santos M., Nogueira-Silva C., La Fuente Carvalho F., Brandão-Nogueira A., Correia-Pinto J., Leite-Moreira A.F. Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway. Endocrinology 2008, 149:4367-4373.
9. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol. 2005, 237:123-130.
10. Hwang I., Ha D., Ahn G., Park E., Joo H., Jee Y. Experimental autoimmune encephalomyelitis: association with mutual regulation of RelA (p65)/NF-κB and phospho-IκB in the CNS. Biochem. Biophys. Res. Commun. 2011, 411(2):464-470.
11. Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of inflammatory process in multiple sclerosis. Scand. J. Immunol. 2011, 74:1-13.
12. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
13. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
14. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
15. Lunin S.M., Glushkova O.V., Khrenov M.O., Parfenyuk S.B., Novoselova T.V., Fesenko E.E., Novoselova E.G. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin. Ther. Targets 2011, 15(12):1337-1346.
16. Lunin S.M., Khrenov M.O., Novoselova T.V., Parfenyuk S.B., Novoselova E.G. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein Hsp70 in inflammation-bearing mice. Immunol. Invest. 2008, 37:858-870.
17. Lunin S.M., Novoselova E.G. Thymus hormones as prospective anti-inflammatory agents. Expert Opin. Ther. Targets 2010, 14(8):775-786.
18. Malaise M.G., Bastings M., Reuter A.M., Vrindts-Gevaert Y., Bernier J., Sondag D., Frère M.C., Goldstein G., Franchimont P. In vitro effects of thymopentin on the gamma-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Immunol. Lett. 1987, 15(4):323-327.
19. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
20. Miljković D., Stanojević Z., Momcilović M., Odoardi F., Flügel A., Mostarica-Stojković M. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats. Immunobiology 2011, 216(9):979-987.
21. Novoselova E.G., Lunin S.M., Khrenov M.O., Cherenkov D.A., Novoselova T.V., Lysenko E.A., Fesenko E.E. Effect of thymopentin on the production of cytokines, heat shock proteins, and NF-kappa B signaling proteins. Biol. Bull. 2008, 35(4):362-367.
22. Novoselova E.G., Lunin S.M., Khrenov M.O., Novoselova T.V., Fesenko E.E. Involvement of NF-kB transcription factor in the antiinflammatory activity of thymic peptides. Dokl. Biol. Sci. 2009, 428:484-486.
23. Ogura H., Murakami M., Okuyama Y., Tsuruoka M., Kitabayashi C., Kanamoto M., Nishihara M., Iwakura Y., Hirano T. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 2008, 29(4):628-636.
24. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
25. Pittock S.J., Lucchinetti C.F. The pathology of MS: new insights and potential clinical applications. Neurologist 2007, 13:45-56.
26. Raine C.S. Multiple Sclerosis. Clinical and Pathogenetic Basis 1997, 243-286. Chapman and Hall, London. H.F. McFarland, W.W. Tourtellotte (Eds.).
27. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514-523.
28. Reggiani P.C., Herenu C.B., Rimoldi O.J., Brown O.A., Pleau J.-M., Dardenne M., Goya R.G. Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. Gene Ther. 2006, 13:1214-1221.
29. Sonobe Y., Jin S., Wang J., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J. Exp. Med. 2007, 213:329-339.
30. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
31. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.